Gufic Biosciences Limited (NSE:GUFICBIO)
India flag India · Delayed Price · Currency is INR
379.60
+5.35 (1.43%)
May 16, 2025, 3:30 PM IST

Revenue by Product

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
Pharmaceutical and Related Products
8.07B
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical and Related Products Growth
16.80%
Log In
Log In
Log In
Log In
Upgrade
Processing Charges
-
Log In
Log In
Log In
Log In
Upgrade
Processing Charges Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is April - March.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2016 - 2018
India
7.19B
Log In
Log In
Log In
Log In
Upgrade
India Growth
23.09%
Log In
Log In
Log In
Log In
Upgrade
Asia
363.02M
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
-29.05%
Log In
Log In
Log In
Log In
Upgrade
Europe
296.40M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
0.74%
Log In
Log In
Log In
Log In
Upgrade
North America
102.38M
Log In
Log In
Log In
Log In
Upgrade
North America Growth
-11.88%
Log In
Log In
Log In
Log In
Upgrade
Africa
58.11M
Log In
Log In
Log In
Log In
Upgrade
Africa Growth
-56.68%
Log In
Log In
Log In
Log In
Upgrade
Australia
42.65M
Log In
Log In
Log In
Log In
Upgrade
Australia Growth
696.53%
Log In
Log In
Log In
Log In
Upgrade
South America
18.89M
Log In
Log In
Log In
Log In
Upgrade
South America Growth
151.80%
Log In
Log In
Log In
Log In
Upgrade